% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Mandel:302795,
      author       = {S. Mandel and T. Hanke and N. Prendiville and M.
                      Baena-Nuevo and L. M. Berger and F. Farges and M. P.
                      Schwalm$^*$ and B.-T. Berger and A. Kraemer and L. Elson and
                      H. Saraswati and K. R. Abdul Azeez and V. Dederer and S.
                      Mathea and A. Corrionero and P. Alfonso and S. Keller and M.
                      Gstaiger and D. S. Krause$^*$ and S. Müller$^*$ and S.
                      Röhm and S. Knapp$^*$},
      title        = {{C}ovalent {T}argeting {L}eads to the {D}evelopment of a
                      {LIMK}1 {I}soform-{S}elective {I}nhibitor.},
      journal      = {Journal of medicinal chemistry},
      volume       = {68},
      number       = {14},
      issn         = {0095-9065},
      address      = {Washington, DC},
      publisher    = {ACS},
      reportid     = {DKFZ-2025-01335},
      pages        = {15026-15049},
      year         = {2025},
      note         = {2025 Jul 24;68(14):15026-15049},
      abstract     = {Selectivity for closely related isoforms of protein kinases
                      is a major challenge in the design of drugs and chemical
                      probes. Covalent targeting of unique cysteines is a
                      potential strategy to achieve selectivity for highly
                      conserved binding sites. Here, we used a pan-LIMK inhibitor
                      to selectively probe LIMK1 over LIMK2 by targeting the
                      LIMK1-specific cysteine C349 located in the glycine-rich
                      loop region. Binding kinetics of both noncovalent and
                      covalent LIMK inhibitors were investigated, and the fast
                      on-rate and small size of type-I inhibitors were used in the
                      design of a covalent LIMK1 inhibitor. The developed
                      cell-active, isoform-selective LIMK1 inhibitor showed
                      excellent proteome-wide selectivity in pull-down assays,
                      enabling studies of LIMK1 isoform-selective functions in
                      cellular model systems and providing a versatile chemical
                      tool for studies of the LIMK signaling pathway.},
      cin          = {FM01},
      ddc          = {610},
      cid          = {I:(DE-He78)FM01-20160331},
      pnm          = {899 - ohne Topic (POF4-899)},
      pid          = {G:(DE-HGF)POF4-899},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:40598933},
      doi          = {10.1021/acs.jmedchem.5c01204},
      url          = {https://inrepo02.dkfz.de/record/302795},
}